header background

Portfolio

Slater’s venture development efforts center around three primary practice areas that have the potential to significantly and positively impact the Rhode Island economy through high-value, high-wage job creation and the further engagement and assimilation of next-generation entrepreneurs into the state’s knowledge base. Concentrated focuses on life sciences, information technology (including software, Internet, and digital media), and energy and the environment aim to achieve the expansion of this economic development ecosystem.

 

Life Sciences

Click to Expand

IlluminOss

lucidux

port_lifesci_mnemosyne

Nabsys

ProThera Biologics

Neurotech

Myomics

cytosolv

EpiVax

medrobotics

Dominion Diagnostics

Selva Medical

Concordia Fibers

Sentient Bioscience

Vitrimark

Cyberkinetics

Software, Internet & Media

Click to Expand

Absolute Commerce

Care Thread

Andera

RxVantage

Mofuse

Dynadec

GeneSpectrum

Location, Inc.

Farsounder

Mathematical Technologies (MTI Film)

Tizra

Insight Health Solutions

Traction Software

Swyx

Advanced Image Enhancement

Energy & Environment

Click to Expand

Enhanced Energy Group

Volt Server

Vcharge

Alektrona

eGo Vehicles

Modular Energy Devices

WeatherPredict Consulting

BioProcess H20

Case Studies

Click to Expand

Nabsys

Modular Energy Devices

ProThera Biologics

Andera

Previous Investments

Click to Expand

Afferent Corporation: focused on the development of a new class of medical devices to treat chronic neurological dysfunction.
Cell Based Delivery: pioneered the engineering of human cells and tissues – primarily from skeletal muscle – to become living drug-delivery systems.
Bionica: developer of a "personal communications system" for the hearing-impaired with innovative design features and proprietary signal software.
Genome Corporation: focused on the development and commercializing of a cost-effective DNA sequencing technology, based upon its proprietary technologies.
Multicell Technologies Inc.: a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer.
P&H Therapeutics: co-founded by former Pfizer researchers to develop next-generation drugs for the treatment of hypertension and dyslipidemia.
Selva Medical
Sention: pharmaceutical developer focused on the discovery and development of drugs to treat memory impairment and other central nervous system disorders.
Spherics: developer of oral pharmaceutical products for central nervous system conditions, gastrointestinal disorders, and cancer.
Tazz Networks: developer of policy control software that enabled service providers to create and deliver services that offer per-session controls designed to assure resource availability and service.